Volpara Health Technologies Ltd (ASX: VHT) Share Price and News

Mr Diddams is the principal of an Australian CPA firm that provides companies with corporate advisory services. Mr Diddams has knowledge and practical experience in the application of Australian corporations law, ASX Listing Rules, international accounting standards, and corporate governance principles. Over the past 30 years, Mr Diddams has managed the processes to raise capital, perform due diligence, and seek ASX listing for a number of enterprises, including IPOs for a wide range of offerings. These include oil and gas interests, food and retail, a fine-wool processing plant, an innovative telephony product, a biotech company, an Internet advertising initiative, a dental device for snoring and sleep apnoea, an indoor skydiving company, the NZ developer of the Martin Jetpack, a healthy fast food chain, and Skydive the Beach Group Limited (now Experience Co Limited). Mr Diddams is currently a Non-Executive Director of Aroa Biosurgery Limited, an NZ-based company that develops and markets proprietary soft-tissue regenerative products; Surf Lakes Holdings Limited, a Gold Coast-based business with patented technology for recreational wave generation; and DIT AgTech Limited, a Queensland-based AgTech company focussed on nutrient supplementation for livestock, using Internet of Things technology to help farmers do more for less. Mr Diddams has recently been appointed Chairman and a Non-Executive Director of xReality Group Limited, a New South Wales company developing and operating physical and digital simulations. He is based in Sydney, Australia.

Mr Allen is an entrepreneur, venture capitalist, and social impact investor and philanthropist whose global career has spanned over 50 years. He helped pioneer the Australian technology industry through the Computer Power Group, one of the first Australian-founded tech companies to scale globally and subsequently IPO in 1987, turning over approx. $1B in today's currency. Following the company's acquisition in 1995, he cofounded Allen & Buckeridge Pty Ltd, one of the first early-stage VC firms. After helping establish two successor VC firms, Allen retired from the firm in 2007 and has since focused on his private VC portfolio of over 50 companies and his many social impact investments. He also established and funded a Public Benevolent Institute called Indigenous Capital Limited (ICL) to focus on indigenous economic development using best practise experience from the technology world. Roger has served on two Prime Ministers' Science and Technology Councils, chaired State Government ICT Advisory Boards, served as deputy Chairman of Austrade for seven years, and been an Adjunct Professor at Swinbourne University, UTS, and INSEAD school of Entrepreneurship in Paris & Singapore. Along with many prestigious industry accolades, in 2011 Allen was awarded the Order of Australia honour for services to IT, venture capital, and in recognition of his support of the Indigenous community and philanthropic sector.

Mr Pavlidis has more than 30 years of experience as a senior healthcare executive, CEO, or company director in the areas of diagnostic imaging, women's health, image analysis and artificial intelligence, and cardiovascular therapies. From 2015 through 2019, Mr Pavlidis served as the President and CEO of Vytronus, Inc., a venture-backed startup using novel catheter-based ultrasound, machine learning, and robotics technology to treat atrial fibrillation, a cardiac arrhythmia. Prior to Vytronus, Mr Pavlidis was the President and CEO of Endoscopic Technologies, Inc., a leader in minimally invasive and endoscopic treatment of atrial fibrillation, until it was acquired by AtriCure, Inc. in 2014. Since 2007, Mr Pavlidis has also served on the board of directors of several health technology companies, including U-systems, Inc., which pioneered automated breast ultrasound imaging as an adjunct to mammography for breast cancer screening and was acquired by GE Healthcare in 2012. Previously, Mr Pavlidis served as President and CEO of R2 Technology, Inc., the pioneer and leader in computerassisted detection of breast cancer, until Hologic, Inc., acquired the company in 2006. Before joining R2 Technology, Mr Pavlidis was president of the global Ultrasound business at Siemens Healthcare, where he led the acquisition and integration of Acuson and subsequent growth of the combined organization to $1 billion in revenue. He shares his time between Europe and the USA.

Mr Reid brings commercial experience gained across a range of technology/Software as a Service (SaaS) businesses. He was the founding CEO and Chairman of Figured Limited, a fintech SaaS company that provides management accounting software to farmers in the USA, United Kingdom, Australia, and New Zealand ("NZ"). Figured was New Zealand's Startup of the Year in 2016 and has grown at an incredible pace, funded by private, corporate and venture capital (VC) investors. He is also currently CEO of Author-it Software Corporation, which provides documentation software for clinical, medical, and labelling information to Life Sciences companies in Europe and the United States of America (USA). Other key directorship roles include Christchurch International Airport Limited and Virsae Group Limited. Prior to embarking on a start-up and governance career, Mr Reid held a number of key executive roles, from CEO to COO, in businesses such as Air New Zealand, MetService, Carter Holt Harvey, and Ernst & Young.

Ms Lindgren joined the Board in 2020. She brings over 35 years' experience in health information technology as a senior technology executive and law firm partner. As one of the earliest healthcare technology lawyers in the US, Ms Lindgren has an in-depth knowledge of data governance, data privacy, SaaS, and US healthcare, and has extensive professional networks across the IT landscape. Her previous roles include General Counsel, Chief Compliance Officer & Chief Privacy Officer at the University Health System Consortium (which covers 90% of US academic medical centers); General Counsel & Chief Privacy Officer at ReedGroup, a data and informatics technology company responsible for absence management solutions at over 50 percent of Fortune 100 companies; and Senior VP, Legal Affairs, General Counsel, Corporate Secretary, Chief Compliance Officer, Chief Privacy Officer, and Chief Audit Executive at Availity, a revenue cycle management, electronic data interchange platform, PaaS IT company that operates the largest real-time information network in healthcare, connecting payers and providers in over seven billion transactions every year. Ms Lindgren was a founding faculty member in the Health Informatics Master's Programs at both Northwestern University (Chicago) and University of Colorado (College of Nursing), and has taught in schools of medicine, law, and business at numerous US universities. She is a board member of multiple private and non-profit organisations. Ms Lindgren is Chair of the Risk Committee and is based in Boulder, Colorado, USA.

Ms Custin brings a network of industry contacts from a career in healthcare across Europe, the Americas, and Asia. Her most recent executive role was with Siemens Healthineers, where she served as both CFO and board director of Siemens Medical Solutions. Prior to this role, Ms Custin served as Chief Operating and Financial Officer of Scient'x and President & CEO of USA Draeger Medical Systems, Inc. Ms Custin is also a Non-Executive Director of NASDAQ-listed Establishment Labs Holdings Inc., a medical technology company focused on women's health, initially in the breast aesthetics and reconstruction market, that has a market capitalisation of approximately US$1.7 billion. Ms Custin recently became a board member of Mayne Pharma Group, a pharmaceutical company based in Australia that develops, manufactures, and markets branded and generic pharmaceutical products globally. Ms Custin is a member of the Audit Committee and is based in Bethlehem, Pennsylvania, USA.

-

-

-

-